Selected research
Market Analysis & Forecast
Global Ticagrelor Market Analysis and Forecast 2026-2032
Market perspective
The global Ticagrelor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Ticagrelor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Ticagrelor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Ticagrelor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Ticagrelor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Ticagrelor include Sun Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, Pfizer, Bayer, Astrazeneca and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Ticagrelor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Ticagrelor, also provides the sales of main regions and countries. Of the upcoming market potential for Ticagrelor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ticagrelor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ticagrelor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ticagrelor sales, projected growth trends, production technology, application and end-user industry.
Ticagrelor Segment by Company
Sun Pharmaceutical
Johnson & Johnson
Merck
Eli Lilly
Pfizer
Bayer
Astrazeneca
Boehringer Ingelheim
Ticagrelor Segment by Type
90 mg Tablet
60 mg Tablet
Ticagrelor Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Ticagrelor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ticagrelor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ticagrelor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ticagrelor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Ticagrelor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Ticagrelor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ticagrelor sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 90 mg Tablet
- 60 mg Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- Bayer
- Astrazeneca
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Ticagrelor Market by Type
- 1.2.1 Global Ticagrelor Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 90 mg Tablet
- 1.2.3 60 mg Tablet
- 1.3 Ticagrelor Market by Application
- 1.3.1 Global Ticagrelor Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacies
- 1.3.3 Online Pharmacies
- 1.3.4 Retail Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Ticagrelor Market Dynamics
- 2.1 Ticagrelor Industry Trends
- 2.2 Ticagrelor Industry Drivers
- 2.3 Ticagrelor Industry Opportunities and Challenges
- 2.4 Ticagrelor Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Ticagrelor Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Ticagrelor Revenue by Region
- 3.2.1 Global Ticagrelor Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Ticagrelor Revenue by Region (2021-2026)
- 3.2.3 Global Ticagrelor Revenue by Region (2027-2032)
- 3.2.4 Global Ticagrelor Revenue Market Share by Region (2021-2032)
- 3.3 Global Ticagrelor Sales Estimates and Forecasts 2021-2032
- 3.4 Global Ticagrelor Sales by Region
- 3.4.1 Global Ticagrelor Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Ticagrelor Sales by Region (2021-2026)
- 3.4.3 Global Ticagrelor Sales by Region (2027-2032)
- 3.4.4 Global Ticagrelor Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Ticagrelor Revenue by Manufacturers
- 4.1.1 Global Ticagrelor Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Ticagrelor Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Ticagrelor Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Ticagrelor Sales by Manufacturers
- 4.2.1 Global Ticagrelor Sales by Manufacturers (2021-2026)
- 4.2.2 Global Ticagrelor Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Ticagrelor Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Ticagrelor Sales Price by Manufacturers (2021-2026)
- 4.4 Global Ticagrelor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Ticagrelor Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Ticagrelor Manufacturers, Product Type & Application
- 4.7 Global Ticagrelor Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Ticagrelor Market CR5 and HHI
- 4.8.2 2025 Ticagrelor Tier 1, Tier 2, and Tier 3
5 Ticagrelor Market by Type
- 5.1 Global Ticagrelor Revenue by Type
- 5.1.1 Global Ticagrelor Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Ticagrelor Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Ticagrelor Revenue Market Share by Type (2021-2032)
- 5.2 Global Ticagrelor Sales by Type
- 5.2.1 Global Ticagrelor Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Ticagrelor Sales by Type (2021-2032) & (k pcs)
- 5.2.3 Global Ticagrelor Sales Market Share by Type (2021-2032)
- 5.3 Global Ticagrelor Price by Type
6 Ticagrelor Market by Application
- 6.1 Global Ticagrelor Revenue by Application
- 6.1.1 Global Ticagrelor Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Ticagrelor Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Ticagrelor Revenue Market Share by Application (2021-2032)
- 6.2 Global Ticagrelor Sales by Application
- 6.2.1 Global Ticagrelor Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Ticagrelor Sales by Application (2021-2032) & (k pcs)
- 6.2.3 Global Ticagrelor Sales Market Share by Application (2021-2032)
- 6.3 Global Ticagrelor Price by Application
7 Company Profiles
- 7.1 Sun Pharmaceutical
- 7.1.1 Sun Pharmaceutical Company Information
- 7.1.2 Sun Pharmaceutical Business Overview
- 7.1.3 Sun Pharmaceutical Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sun Pharmaceutical Ticagrelor Product Portfolio
- 7.1.5 Sun Pharmaceutical Recent Developments
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Company Information
- 7.2.2 Johnson & Johnson Business Overview
- 7.2.3 Johnson & Johnson Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson & Johnson Ticagrelor Product Portfolio
- 7.2.5 Johnson & Johnson Recent Developments
- 7.3 Merck
- 7.3.1 Merck Company Information
- 7.3.2 Merck Business Overview
- 7.3.3 Merck Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Merck Ticagrelor Product Portfolio
- 7.3.5 Merck Recent Developments
- 7.4 Eli Lilly
- 7.4.1 Eli Lilly Company Information
- 7.4.2 Eli Lilly Business Overview
- 7.4.3 Eli Lilly Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Eli Lilly Ticagrelor Product Portfolio
- 7.4.5 Eli Lilly Recent Developments
- 7.5 Pfizer
- 7.5.1 Pfizer Company Information
- 7.5.2 Pfizer Business Overview
- 7.5.3 Pfizer Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Pfizer Ticagrelor Product Portfolio
- 7.5.5 Pfizer Recent Developments
- 7.6 Bayer
- 7.6.1 Bayer Company Information
- 7.6.2 Bayer Business Overview
- 7.6.3 Bayer Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Bayer Ticagrelor Product Portfolio
- 7.6.5 Bayer Recent Developments
- 7.7 Astrazeneca
- 7.7.1 Astrazeneca Company Information
- 7.7.2 Astrazeneca Business Overview
- 7.7.3 Astrazeneca Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Astrazeneca Ticagrelor Product Portfolio
- 7.7.5 Astrazeneca Recent Developments
- 7.8 Boehringer Ingelheim
- 7.8.1 Boehringer Ingelheim Company Information
- 7.8.2 Boehringer Ingelheim Business Overview
- 7.8.3 Boehringer Ingelheim Ticagrelor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Boehringer Ingelheim Ticagrelor Product Portfolio
- 7.8.5 Boehringer Ingelheim Recent Developments
8 North America
- 8.1 North America Ticagrelor Market Size by Type
- 8.1.1 North America Ticagrelor Revenue by Type (2021-2032)
- 8.1.2 North America Ticagrelor Sales by Type (2021-2032)
- 8.1.3 North America Ticagrelor Price by Type (2021-2032)
- 8.2 North America Ticagrelor Market Size by Application
- 8.2.1 North America Ticagrelor Revenue by Application (2021-2032)
- 8.2.2 North America Ticagrelor Sales by Application (2021-2032)
- 8.2.3 North America Ticagrelor Price by Application (2021-2032)
- 8.3 North America Ticagrelor Market Size by Country
- 8.3.1 North America Ticagrelor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Ticagrelor Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Ticagrelor Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Ticagrelor Market Size by Type
- 9.1.1 Europe Ticagrelor Revenue by Type (2021-2032)
- 9.1.2 Europe Ticagrelor Sales by Type (2021-2032)
- 9.1.3 Europe Ticagrelor Price by Type (2021-2032)
- 9.2 Europe Ticagrelor Market Size by Application
- 9.2.1 Europe Ticagrelor Revenue by Application (2021-2032)
- 9.2.2 Europe Ticagrelor Sales by Application (2021-2032)
- 9.2.3 Europe Ticagrelor Price by Application (2021-2032)
- 9.3 Europe Ticagrelor Market Size by Country
- 9.3.1 Europe Ticagrelor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Ticagrelor Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Ticagrelor Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Ticagrelor Market Size by Type
- 10.1.1 China Ticagrelor Revenue by Type (2021-2032)
- 10.1.2 China Ticagrelor Sales by Type (2021-2032)
- 10.1.3 China Ticagrelor Price by Type (2021-2032)
- 10.2 China Ticagrelor Market Size by Application
- 10.2.1 China Ticagrelor Revenue by Application (2021-2032)
- 10.2.2 China Ticagrelor Sales by Application (2021-2032)
- 10.2.3 China Ticagrelor Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Ticagrelor Market Size by Type
- 11.1.1 Asia Ticagrelor Revenue by Type (2021-2032)
- 11.1.2 Asia Ticagrelor Sales by Type (2021-2032)
- 11.1.3 Asia Ticagrelor Price by Type (2021-2032)
- 11.2 Asia Ticagrelor Market Size by Application
- 11.2.1 Asia Ticagrelor Revenue by Application (2021-2032)
- 11.2.2 Asia Ticagrelor Sales by Application (2021-2032)
- 11.2.3 Asia Ticagrelor Price by Application (2021-2032)
- 11.3 Asia Ticagrelor Market Size by Country
- 11.3.1 Asia Ticagrelor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Ticagrelor Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Ticagrelor Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Ticagrelor Market Size by Type
- 12.1.1 SAMEA Ticagrelor Revenue by Type (2021-2032)
- 12.1.2 SAMEA Ticagrelor Sales by Type (2021-2032)
- 12.1.3 SAMEA Ticagrelor Price by Type (2021-2032)
- 12.2 SAMEA Ticagrelor Market Size by Application
- 12.2.1 SAMEA Ticagrelor Revenue by Application (2021-2032)
- 12.2.2 SAMEA Ticagrelor Sales by Application (2021-2032)
- 12.2.3 SAMEA Ticagrelor Price by Application (2021-2032)
- 12.3 SAMEA Ticagrelor Market Size by Country
- 12.3.1 SAMEA Ticagrelor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Ticagrelor Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Ticagrelor Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Ticagrelor Value Chain Analysis
- 13.1.1 Ticagrelor Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Ticagrelor Production Mode & Process
- 13.2 Ticagrelor Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Ticagrelor Distributors
- 13.2.3 Ticagrelor Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst